Alembic

Work as Executive / Sr. Executive – Quality Control (API) 

BIPER (Bangalore), Rajiv Institute of Pharmacy (Kerala)

Faculty Job in Pharmaceutical Chemistry, Pharmacology, Pharmaceutics

Wockhardt 

Medical Representative

Cactus Commnication

Vacancy for Medical Writer

Sastra University

Project Fellow in pharmacology

Applications are invited for 3 temporary posts of Project Fellow for the DST project entitled “In-vivo standardization of Siddha herbalf formulation for obesity” for a period of one year extendable for further one year.

Alembic Pharma

Job as Group Product Manager / Product Manager

CLINIMINDS

Require Training-Co-ordinators

Dr. Reddy's Lab

Job in Manufacturing-Formulation

January 8, 2010 — Patients with pernicious anemia have significantly higher risks for hip fracture, research shows.

Compared to age- and sex-matched controls, patients with pernicious anemia had a 73% greater risk of hip fracture (3.4 vs. 2.0 hip fractures/1000 person-years of follow-up). The elevated risk was even greater with newly diagnosed pernicious anemia (HR, 2.63).

January 8, 2010 — Thoracoabdominal calcifications on radiography predict cardiovascular and total mortality, according to the results of an 18-year follow-up study reported online in the December 15, 2009, issue of Diabetes Care.

Sopherion Therapeutics, LLC, a bio-pharmaceutical company focused on the development and commercialization of anti-cancer therapies, announced that it has received Fast Track Designation from the US Food and Drug Administration (FDA) for nonpegylated liposomal doxorubicin (Myocet) for first-line therapy of HER2 positive metastatic breast cancer. Treatment with Myocet has already shown a reduced level of cardiotoxicity as compared to traditional doxorubicin.

Stride Arcolabs

Work as Head / Manager – BD (International Operations)

NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH (NIPER), 2010